Navy Medicine and Army Medicine Researchers Submit Provisional Patent for Antimicrobial Therapy

SILVER SPRING, Md. – Yoann Le Breton, with Naval Medical Research Command (NMRC), and Evelina Angov, with the Walter Reed Army Institute of Research (WRAIR), submitted a provisional patent application for an antimicrobial, non-antibiotic solution to wound care on July 17.

SILVER SPRING, Md. (Aug. 25, 2025) Mackenzie Ryan, a microbiologist with Naval Medical Research Command (NMRC), inspects a sample to aid research testing antimicrobial therapies. Research is being conducted to treat Staphylococcus aureus, a dangerous and frequently drug-resistant bacteria that is often associated with wound infections. Developing an antibiotic alternative that is easily accessible will allow service members to have better resources in environments where traditional healthcare is not available. NMRC, headquarters of Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. (U.S. Navy photo by Aleece Williams/Released)

Lost Password